Medicine
Atomoxetine 18 mg capsule
Atomoxetine 18 mg capsule is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Atomoxetine
- Brand
- Sold under the generic name
- Strength
- 18 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 2000 capsules, 30 capsules, 500 capsules and 17 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaGlenmark PharmaceuticalsIndiaStrides PharmaIndiaCamber PharmaceuticalsIndiaCreekwood PharmaceuticalsApotexAvKAREBryant Ranch PrepackGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06BA09 Atomoxetine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 May 2017
- Identifiers
- RxCUI 349591, 349592, 349593 +4DailyMed set ID 9b757805-eabf-4301-85be-7a3e38f6b187, 9c1f858c-8721-49e3-be8b-bf180e89ff42, 1cceab35-dc4a-40bc-a245-10b64820e217 +11NDC 82619-116, 72162-2542, 64980-374 +11Application ANDA218875, ANDA079021, ANDA079016 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2000 capsule in 1 bottle | 65862-239-22 | Aurobindo PharmaIndia | 30 May 2017 |
| 30 capsule in 1 bottle | 65862-239-30 | Aurobindo PharmaIndia | 30 May 2017 |
| 30 capsule in 1 bottle | 31722-715-30 | Camber PharmaceuticalsIndia | 11 March 2021 |
| 500 capsule in 1 bottle | 55111-520-05 | Dr. Reddy's LaboratoriesIndia | 23 February 2018 |
| 30 capsule in 1 bottle | 55111-520-30 | Dr. Reddy's LaboratoriesIndia | 23 February 2018 |
| 100 blister pack in 1 carton / 10 capsule in 1 blister pack | 55111-520-78 | Dr. Reddy's LaboratoriesIndia | 23 February 2018 |
| 2000 capsule in 1 bottle | 68462-266-23 | Glenmark PharmaceuticalsIndia | 30 May 2017 |
| 30 capsule in 1 bottle | 68462-266-30 | Glenmark PharmaceuticalsIndia | 30 May 2017 |
| 30 capsule in 1 bottle, plastic | 64380-473-01 | Strides PharmaIndia | 1 July 2025 |
| 500 capsule in 1 bottle, plastic | 64380-473-02 | Strides PharmaIndia | 1 July 2025 |
| 30 capsule in 1 bottle | 60505-2831-3 | Apotex | 21 May 2018 |
| 30 capsule in 1 bottle | 82619-116-01 | Creekwood Pharmaceuticals | 6 July 2026 |
| 500 capsule in 1 bottle | 82619-116-02 | Creekwood Pharmaceuticals | 6 July 2026 |
| 30 capsule in 1 bottle | 64980-374-03 | Rising Pharma Holdings | 30 May 2017 |
| 30 capsule in 1 bottle | 0093-3543-56 | Teva Pharmaceuticals | 30 May 2017 |
| 30 capsule in 1 bottle | 42291-065-30 | AvKARE | 12 April 2022 |
| 30 capsule in 1 bottle | 72162-2542-3 | Bryant Ranch Prepack | 16 October 2025 |
| 30 capsule in 1 bottle | 51407-101-30 | Golden State Medical Supply | 7 June 2018 |
| 30 capsule in 1 bottle | 16714-756-01 | Northstar Rx | 1 June 2018 |
| 30 capsule in 1 bottle | 72603-436-01 | NorthStar RxLLC | 2 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 November 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Atomoxetine 18 mg capsule.
Other strengths and forms of Atomoxetine
Clinical summary
Atomoxetine is a norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients 6 years of age and older, among other approved uses. It is available as capsules and oral solution. MedsAcross supplies Atomoxetine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtomoxetineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Strattera prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
Need Atomoxetine 18 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.